K V Pharmaceutical Co. Class A (NYSE:KV-A)
CAPS Rating:
Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.
RSS Headlines
Fool UK
Recs
Alright, I''ve rode this up and then red thumbed it and rode it down. It's priced to be a good choice for the long run again.